Projects per year
Personal profile
Campus career
医学科 助教 2012/10/01-2018/03/31
東西統合医学系 助教 2012/10/01-2018/03/31
附属病院 助教 2022/04/01-
医学系 助教 2022/04/01-
東西統合医学系 助教 2012/10/01-2018/03/31
附属病院 助教 2022/04/01-
医学系 助教 2022/04/01-
Research Fields, Keywords
- Ophthalmology
- Uveitis
- Retina
Fingerprint
Dive into the research topics where Tomoko Nakamura is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Visualization of critical neuronal circuits for the determination of diurnal animal behaviors using bioluminescence imaging
Ikeda, M. (PI), Nakamura, T. (CoI), Konno, N. (CoI) & Morioka, E. (CoI)
2021/04/01 → 2024/03/31
Project: Research
-
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study)
International Retina Biosimilar Study Group (Inter BIOS Group), 2025, (Accepted/In press) In: Eye (Basingstoke). 294.Research output: Contribution to journal › Article › peer-review
-
Assessment of retinal pigment epithelium tears in eyes with submacular hemorrhage secondary to age-related macular degeneration
Ueda-Consolvo, T., Takahashi, S., Oiwake, T., Nakamura, T., Ishida, M., Yanagisawa, S. & Hayashi, A., 2025/12, In: Scientific Reports. 15, 1, 3606.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)
International Retina Biosimilar Study Group (Inter BIOS Group), 2024/12, In: Eye (Basingstoke). 38, 17, p. 3392-3395 4 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study)
International Retina Biosimilar Study Group (Inter BIOS Group), 2024/11, In: Eye (Basingstoke). 38, 16, p. 3193-3196 4 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study
Ueda-Consolvo, T., Tanigichi, A., Numata, A., Oiwake, T., Nakamura, T., Ishida, M., Yanagisawa, S. & Hayashi, A., 2023/02, In: Graefe's Archive for Clinical and Experimental Ophthalmology. 261, 2, p. 345-352 8 p.Research output: Contribution to journal › Article › peer-review
14 Scopus citations